Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Non-Current Debt (2020)

Historic Non-Current Debt for Lexaria Bioscience (LEXX) over the last 3 years, with Q4 2020 value amounting to $30852.0.

  • Lexaria Bioscience's Non-Current Debt changed N/A to $30852.0 in Q4 2020 from the same period last year, while for Nov 2020 it was $30852.0, marking a year-over-year change of. This contributed to the annual value of $30670.0 for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q4 2020, Lexaria Bioscience's Non-Current Debt is $30852.0.
  • Lexaria Bioscience's Non-Current Debt's 5-year high stood at $30852.0 during Q4 2020, with a 5-year trough of $28756.0 in Q2 2020.